Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in PGEN — Precigen, Inc.

CIK 1167557 Greenwich, CT
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$829,917
+$113,994 QoQ
Shares Held
145,600
-21.3% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 210 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. PGEN ranks #164 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in PGEN

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $829,917 145,600
2026-03-31 $715,923 184,994
2025-12-31 $779,150 186,400
2025-09-30 $350,254 106,461
2025-06-30 $167,084 117,666
2025-03-31 $94,135 63,179
2024-12-31 $22,325 19,934
2024-09-30 $15,096 15,893
2024-06-30 $79,003 50,002
2024-03-31 $46,262 31,905
2023-09-30 $122,991 86,614
2023-06-30 $164,261 142,836
2023-03-31 $376,792 355,465
2022-12-31 $831,281 546,896
2022-09-30 $1,313,098 619,386
2022-06-30 $654,993 488,801
2022-03-31 $568,016 269,202
2021-12-31 $805,715 217,174
2021-09-30 $365,178 73,182
2021-06-30 $333,569 51,161
2021-03-31 $595,116 86,374